Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03
Published September 21, 2022 · Recall initiated: September 13, 2022
Summary
FDA records drug Class II recall D-1536-2022, published September 21, 2022 and initiated September 13, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 11,802 1000-count bottles; Lot: Lot # Q201182, exp. date March 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
What to do
Voluntary: Firm initiated · Letter
Get an email if LISINOPRIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LISINOPRIL
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to major distributors/wholesalers nationwide.
- UPC
- 0368180513018
- Lot
- Lot # Q201182, exp. date March 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716,November 27, 2024
- FDATriamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Direct Rx, Dawsonville,September 21, 2022
- FDASynergy Hand Sanitizer, Non-Sterile Solution to help reduce bacteria that can potentially cause disease, ForSeptember 21, 2022
- FDALisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePointAugust 5, 2020
- FDALisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc.,June 17, 2020
- FDALisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.,April 8, 2020
Questions about this recall
Was Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03 recalled?
Yes. FDA published recall D-1536-2022 on September 21, 2022. Reported hazard: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LISINOPRIL. UPC: 0368180513018.